ESSA Pharma snags $49m in funding, Pfizer among the investors

Vancouver, British Columbia-based ESSA Pharma secured US$49 million in a public offering that included investments by the pharmaceutical company's venture capital backers.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this